Northern Trust’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.6M | Sell |
784,213
-72,868
| -9% | -$2.1M | ﹤0.01% | 1574 |
|
|
2025
Q1 | $28.7M | Sell |
857,081
-22,733
| -3% | -$762K | ﹤0.01% | 1414 |
|
|
2024
Q4 | $45M | Buy |
879,814
+149,298
| +20% | +$7.63M | 0.01% | 1192 |
|
|
2024
Q3 | $37.3M | Buy |
730,516
+124,479
| +21% | +$6.36M | 0.01% | 1223 |
|
|
2024
Q2 | $27.1M | Buy |
606,037
+4,653
| +0.8% | +$208K | ﹤0.01% | 1365 |
|
|
2024
Q1 | $28.2M | Sell |
601,384
-1,038
| -0.2% | -$48.6K | ﹤0.01% | 1360 |
|
|
2023
Q4 | $21.4M | Buy |
602,422
+5,098
| +0.9% | +$181K | ﹤0.01% | 1567 |
|
|
2023
Q3 | $17.8M | Buy |
597,324
+106,594
| +22% | +$3.17M | ﹤0.01% | 1626 |
|
|
2023
Q2 | $8.84M | Buy |
490,730
+13,442
| +3% | +$242K | ﹤0.01% | 2152 |
|
|
2023
Q1 | $7.67M | Sell |
477,288
-3,512
| -0.7% | -$56.4K | ﹤0.01% | 2201 |
|
|
2022
Q4 | $8.8M | Buy |
480,800
+2,418
| +0.5% | +$44.2K | ﹤0.01% | 2094 |
|
|
2022
Q3 | $9.4M | Sell |
478,382
-5,899
| -1% | -$116K | ﹤0.01% | 2018 |
|
|
2022
Q2 | $9.03M | Buy |
484,281
+43,757
| +10% | +$816K | ﹤0.01% | 2103 |
|
|
2022
Q1 | $9.67M | Sell |
440,524
-10,004
| -2% | -$220K | ﹤0.01% | 2164 |
|
|
2021
Q4 | $12.8M | Buy |
450,528
+83,529
| +23% | +$2.37M | ﹤0.01% | 2067 |
|
|
2021
Q3 | $7.73M | Buy |
366,999
+885
| +0.2% | +$18.6K | ﹤0.01% | 2463 |
|
|
2021
Q2 | $6.9M | Buy |
366,114
+70,721
| +24% | +$1.33M | ﹤0.01% | 2627 |
|
|
2021
Q1 | $4.51M | Sell |
295,393
-22,143
| -7% | -$338K | ﹤0.01% | 2821 |
|
|
2020
Q4 | $4.48M | Sell |
317,536
-8,145
| -3% | -$115K | ﹤0.01% | 2743 |
|
|
2020
Q3 | $5.1M | Buy |
325,681
+115,751
| +55% | +$1.81M | ﹤0.01% | 2514 |
|
|
2020
Q2 | $3.68M | Buy |
209,930
+47,585
| +29% | +$833K | ﹤0.01% | 2702 |
|
|
2020
Q1 | $2.39M | Buy |
162,345
+13,903
| +9% | +$204K | ﹤0.01% | 2755 |
|
|
2019
Q4 | $3.73M | Buy |
148,442
+12,793
| +9% | +$321K | ﹤0.01% | 2765 |
|
|
2019
Q3 | $2.04M | Buy |
135,649
+27,905
| +26% | +$420K | ﹤0.01% | 3097 |
|
|
2019
Q2 | $2.69M | Buy |
107,744
+3,415
| +3% | +$85.4K | ﹤0.01% | 2897 |
|
|
2019
Q1 | $2.38M | Buy |
104,329
+27,602
| +36% | +$628K | ﹤0.01% | 2967 |
|
|
2018
Q4 | $2.3M | Buy |
76,727
+498
| +0.7% | +$14.9K | ﹤0.01% | 2969 |
|
|
2018
Q3 | $2.18M | Buy |
+76,229
| New | +$2.18M | ﹤0.01% | 3166 |
|